Using Optical Genome Mapping and NGS to Understand Epitheliod Sarcoma in a Pediatric Patient

Combining traditional next generation sequencing with optical genome mapping presents a robust picture of the precise genomic alterations.

Anthony MaglioccoMay 5, 2022

Embryonal Rhabdomyosarcoma in a Pediatric Patient: Therapeutic Target Identification

A rare pediatric soft tissue tumor was analyzed to determine therapeutic targets. By combining multiple types of analysis, it was uncovered that this patient was eligible for a novel clinical trial containing MEK and PD-L1 checkpoint inhibitors.

Anthony MaglioccoMay 5, 2022

Protean Presents on Key Genetic Characteristics of Pediatric AML Between Black/African Americans and Caucasians

Acute Myeloid Leukemia (AML) constitutes 15-20% of all pediatric acute leukemias, with an average survival rate of 70%. However, the black/African American subgroup do significantly worse than whites with AML.

Anthony MaglioccoMay 4, 2022

Dr. Magliocco Featured in Article on Genomic Profiling

Protean BioDiagnostics develops AI approach to detect specific EGFR mutations in lung cancer specimens using analysis of digital pathology images and will present findings at the AACR meeting.

Anthony MaglioccoApril 14, 2022

Protean to Present Advanced AI Research at AACR22

Protean BioDiagnostics develops AI approach to detect specific EGFR mutations in lung cancer specimens using analysis of digital pathology images and will present findings at the AACR meeting.

Anthony MaglioccoApril 8, 2022

Protean to Present Novel Research Findings on Colorectal Cancer at AACR22

Protean BioDiagnostics identifies key molecular differences in Colorectal cancer between men and women with implications for treatment and screening.

Anthony MaglioccoApril 4, 2022